SUNY-Buffalo: New Research Aims to Uncover Role of Genetics in Heart Damage From Chemotherapy in Children With Down Syndrome
October 12, 2019
October 12, 2019
BUFFALO, New York, Oct. 12 [TNSmedicalresearch] -- The State University of New York Buffalo campus issued the following news release:
The University at Buffalo has been awarded a $438,000 grant from the National Cancer Institute to explore the prevention of drug-related heart damage in children with Down syndrome and the blood cancer, acute myeloid leukemia.
The research, led by Javier G. Blanco, PhD, professor in the UB School of Pharmacy and Pharmaceutical Sciences, w . . .
The University at Buffalo has been awarded a $438,000 grant from the National Cancer Institute to explore the prevention of drug-related heart damage in children with Down syndrome and the blood cancer, acute myeloid leukemia.
The research, led by Javier G. Blanco, PhD, professor in the UB School of Pharmacy and Pharmaceutical Sciences, w . . .